IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Bio Medica Laboratories IPO is a Book Building listing on NSE SME exchange, with an ipo size of ₹ [●] Cr. The company is based in Indore and caters to Pharmaceutical sector. Narnolia Financial Services is the merchant banker of Bio Medica Laboratories IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th August 2025.
Bio Medica Laboratories IPO posted revenues of ₹ 38.19 Cr. and PAT of ₹ 9.79 Cr. in FY25 on annualised basis.
Revenue:
₹ 38.19 Cr.
EBITDA Margin:
40.14
% 
Net Worth: ₹ 7.39 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 0.98 times
Financial results of Bio Medica Laboratories IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY25 | FY24 | FY23 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 39.11 | 19.53 | 17.56 | ||
| Net Worth | 7.39 | 8.03 | 4.94 | ||
| Total Debt | 15.00 | 9.98 | 9.60 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
38.19 | 15.24 | 16.22 | ||
EBITDA
EBITDA on annualised basis |
15.33 | 5.72 | 1.71 | ||
PAT
PAT on annualised basis |
9.79 | 2.49 | 0.33 | ||
Bio Medica Laboratories IPO PAT Margin is 25.63 % , ROCE (Return on Capital Employed) is 48.20 % as per latest financial. The below table shows Bio Medica Laboratories IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY25 | FY24 | FY23 |
|---|---|---|---|
| EBITDA Margin (%) | 40.14 | 37.53 | 10.54 |
| PAT Margin (%) | 25.63 | 16.34 | 2.03 |
| EPS (₹) | 10.67 | 2.72 | 0.36 |
| ROE (%) | 132.48 | 31.01 | 6.68 |
| ROCE (%) | 48.20 | 29.92 | 10.16 |
| ROA (%) | 25.03 | 12.75 | 1.88 |
| Debt to Equity | 2.03 | 1.24 | 1.94 |
The market Capitalisation of Bio Medica Laboratories IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Bio Medica Laboratories IPO prospectus highlights an Return on Equity (ROE) of 132.48 % , Return on Assets (ROA) of 25.03 %, and an EBITDA Margin of 40.14 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Bio Medica Laboratories IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Bio Medica Laboratories IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Bio Medica Laboratories IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Bio Medica Laboratories IPO reported revenue of ₹ 38.19 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Bio Medica Laboratories IPO provide insights into sales growth, market demand, and business scalability.
Bio Medica Laboratories recorded an EBITDA of ₹ 15.33 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Bio Medica Laboratories Profit After Tax (PAT) is ₹ 9.79 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 38.19 Cr.
EBITDA Margin:
40.14
%
Net Worth: ₹ 7.39 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA:
[●]
Bio Medica Laboratories operates in Pharmaceutical and Manufacturing Of Pharmaceutical Parenteral Formulations. The Issue is listed on NSE SME in Aug, 2025. Bio Medica Laboratories IPO size was with Issue price of .
Merchant Banker(s) of Bio Medica Laboratories IPO: Narnolia Financial Services Limited
Bio Medica Laboratories IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Bio Medica Laboratories IPO listed at a listing price of against the offer price of .
The current market price of Bio Medica Laboratories is .
Why Us?
